StockData
ADC Therapeutics SA logo

ADC Therapeutics SA (ADCT) income statement

ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.28−0.02 (-1.54%)

Close on Nov 20, 2026Market cap $163.42MP/E –Yield –

See a number that looks wrong?